Citadel Advisors’s ProAssurance PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,200
Closed -$50.9K 15341
2024
Q4
$50.9K Buy
3,200
+2,900
+967% +$46.1K ﹤0.01% 12373
2024
Q3
$4.51K Buy
+300
New +$3.83K ﹤0.01% 13560
2024
Q2
Sell
-87,000
Closed -$1.12M 15133
2024
Q1
$1.12M Buy
87,000
+53,000
+156% +$682K ﹤0.01% 6700
2023
Q4
$469K Buy
+34,000
New +$520K ﹤0.01% 8255
2023
Q3
Sell
-11,000
Closed -$166K 14910
2023
Q2
$166K Buy
11,000
+4,600
+72% +$72.4K ﹤0.01% 10173
2023
Q1
$118K Buy
6,400
+4,100
+178% +$77.1K ﹤0.01% 11020
2022
Q4
$40.2K Buy
+2,300
New +$45.3K ﹤0.01% 12414

Other funds holding PRA

Citadel Advisors's PRA Position: Q2 2026 in Review

Citadel Advisors sold out of ProAssurance (PRA) in Q2 2026, closing a stake of 52,071 shares — an estimated $1.29M sold.

Citadel Advisors first reported a position in PRA in Q2 2013 and held it in 45 quarters. The position peaked at $57.3M in Q4 2013. 2 funds tracked by Wall St. Rank hold PRA as of Q2 2026.

  • Citadel Advisors reported no remaining ProAssurance position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 52,071 ProAssurance shares in Q2 2026, an estimated $1.29M.
  • Citadel Advisors first reported a position in ProAssurance in Q2 2013 and held it in 45 quarters.
  • Citadel Advisors's ProAssurance position peaked at $57.3M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held ProAssurance as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.